Johnson & Johnson halts Covid-19 vaccine trial after patient gets unexplained illness


WASHINGTON (AFP): Johnson & Johnson said Monday (Oct 12) it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.

“We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant, ” the company said in a statement.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
   

Next In World

Canada apologizes to Inuit communities for mass killing of sled dogs decades ago
Putin signs law forgiving debt arrears for new Russian recruits for Ukraine war
European Film Festival kicks off in Libya's Tripoli
Feature: China-funded training benefits Myanmar's tourism sector
Thousands protest in Valencia over lack of schools after deadly floods
Barcelona protesters demand affordable rents as Spain juggles tourism impact
Gaza highlighted at Cairo Int'l Film Festival, Palestinian filmmakers awarded
COP29 agrees deal to kick-start global carbon credit trading
Feature: Namibian cultural group tackles social issues, creating opportunities with traditional dance
Israel suspects disappearance of Jewish religious emissary in UAE linked to terrorist act

Others Also Read